Literature DB >> 12914975

Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain.

Lumír Hanus1, Yosefa Avraham, Dikla Ben-Shushan, Olga Zolotarev, Elliot M Berry, Raphael Mechoulam.   

Abstract

2-Arachidonoyl glycerol (2-AG) levels in whole mouse brain and two of its regions-hippocampus and hypothalamus-were determined after diet restriction (between 60 and 40%) lasting 12 days. The diet restriction lowered the level of 2-AG, which in the hypothalamus depended on the severity of the diet restriction, while the level in the hippocampus was not dependent on the diet regimen. As these observations differ from previously published data showing elevation of 2-AG levels in rat brain after 24 h of severe food restriction, we measured 2-AG levels in whole mouse brain after a comparable period of full starvation (fasting). We confirmed the elevation of 2-AG levels. It seems possible that these time-dependent variations of 2-AG levels may be of importance as a general coping strategy by animals during periods of starvation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12914975     DOI: 10.1016/s0006-8993(03)03046-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

Review 1.  Endocannabinoid system overactivity and the metabolic syndrome: prospects for treatment.

Authors:  Jennifer M Perkins; Stephen N Davis
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

Review 2.  Endocannabinoid signalling: has it got rhythm?

Authors:  Linda K Vaughn; Gerene Denning; Kara L Stuhr; Harriet de Wit; Matthew N Hill; Cecilia J Hillard
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

3.  CB1 cannabinoid receptor-mediated modulation of food intake in mice.

Authors:  Jenny L Wiley; James J Burston; Darnica C Leggett; Olga O Alekseeva; Raj K Razdan; Anu Mahadevan; Billy R Martin
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

Review 4.  Prolonged fasting as a method of mood enhancement in chronic pain syndromes: a review of clinical evidence and mechanisms.

Authors:  Andreas Michalsen
Journal:  Curr Pain Headache Rep       Date:  2010-04

5.  Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa.

Authors:  Cindy Casteels; Nathalie Gérard; Kris van Kuyck; Lies Pottel; Bart Nuttin; Guy Bormans; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-05       Impact factor: 9.236

Review 6.  New horizons on the role of cannabinoid CB1 receptors in palatable food intake, obesity and related dysmetabolism.

Authors:  L Cristino; L Palomba; V Di Marzo
Journal:  Int J Obes Suppl       Date:  2014-07-08

7.  Enhanced Glutamatergic Synaptic Plasticity in the Hippocampal CA1 Field of Food-Restricted Rats: Involvement of CB1 Receptors.

Authors:  Giuseppe Talani; Valentina Licheri; Francesca Biggio; Valentina Locci; Maria Cristina Mostallino; Pietro Paolo Secci; Valentina Melis; Laura Dazzi; Gianfranca Carta; Sebastiano Banni; Giovanni Biggio; Enrico Sanna
Journal:  Neuropsychopharmacology       Date:  2015-09-10       Impact factor: 7.853

8.  Cannabinoid CB1 /CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia.

Authors:  Maria Scherma; Valentina Satta; Roberto Collu; Maria Francesca Boi; Paolo Usai; Walter Fratta; Paola Fadda
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

9.  Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice.

Authors:  Y Avraham; N C Grigoriadis; I Magen; T Poutahidis; L Vorobiav; O Zolotarev; Y Ilan; R Mechoulam; E M Berry
Journal:  Br J Pharmacol       Date:  2009-09-18       Impact factor: 8.739

10.  Food restriction, refeeding, and gastric fill fail to affect emesis in musk shrews.

Authors:  Charles C Horn; Liz Still; Christiana Fitzgerald; Mark I Friedman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-05       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.